Axsome Therapeutics, Inc. AXSM 深 沪
等待开盘 06-26 09:30:00 美东时间
237.17
-0.750
-0.32%
华盛通- 最 高253.00
- 今 开238.83
- 成交量 84.07万股
- 最 低 236.44
- 昨 收 237.92
- 总市值 922.91万
- 52周最高 260.19
- 市盈率 静 --
- 换手率 2160.34%
- 52周最低 96.09
- 委 比 86.77%
- 总股本 3.89万
- 历史最高 260.19
- 量 比 0.82
- 振 幅 6.96%
- 历史最低 1.10
- 每 手 1
- 风险率 41.35%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Axsome Therapeutics Resolves All Patent Litigation Related To Axsome's Product SUNOSI
Axsome Therapeutics, Inc. (NASDAQ:AXSM) (Axsome), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, today announced that it has resolved all patent litigation
06-03 19:07
Strong Drug Sales Lift Axsome Revenue, But Profit Miss Drags Stock
Axsome (AXSM) Q1: Revenue beats, but wider loss and rising expenses weigh on shares. Get the key data on Sunosi and Auvelity sales.
05-04 20:18
Earnings Scheduled For May 4, 2026
Companies Reporting Before The Bell • Pulse Biosciences (NASDAQ:PLSE) is likely...
05-04 19:11
Axsome Stock Climbs On Schizophrenia Drug Deal With Takeda
Axsome gains after securing global rights to balipodect from Takeda, advancing schizophrenia pipeline amid bullish analyst targets.
04-02 01:36
Earnings Scheduled For February 23, 2026
Companies Reporting Before The Bell • Domino's Pizza (NASDAQ:DPZ) is likely to ...
02-23 19:11
Neumora Therapeutics Stock Jumps, Analyst Sees Upside In Alzheimer's Treatment
William Blair upgrades Neumora after strong Alzheimer's agitation data, sees upside from NMRA-511 and obesity pipeline potential.
02-18 03:32
FDA Fast-Tracks Axsome's Alzheimer's Agitation Drug, Stock Soars
The FDA accepted Axsome Therapeutics Inc.'s supplemental NDA for AXS-05 for Alzheimer's agitation with a Priority Review date.
2025-12-31 23:30
Earnings Scheduled For November 3, 2025
Companies Reporting Before The Bell • CNA Financial (NYSE:CNA) is expected to r...
2025-11-03 19:11
Uncovering Potential: Axsome Therapeutics's Earnings Preview
Axsome Therapeutics (NASDAQ:AXSM) is set to give its latest quarterly earnings ...
2025-11-01 02:01
广发证券：焦炭第二和第三轮提涨连续落地 后续供应收缩预期加强支撑煤价上行
炒股就看金麒麟分析师研报，权威，专业，及时，全面，助您挖掘潜力主题机会！ 广发证券发布研报称，近期，各煤种价格普涨，焦炭第二和第三轮提涨连续落地。当前煤炭...
2025-08-05 16:27
